You searched for "regenerative"
The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy
The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...
Beta blocker treatment for capillary haemangioma
This randomised controlled trial of 25 patients aimed to evaluate the safety and efficacy of combined oral and topical beta blockers for the treatment of superficial periocular infantile capillary haemangioma at the early proliferative stage. Group 1 (n=13) were given...
Control of diabetic retinopathy after bariatric surgery
This systemic review and meta-analysis assessed prevalence of diabetic retinopathy including sight-threatening diabetic retinopathy after surgery. They included 14 studies with 110,300 surgical patients and 252,289 control subjects. They proposed that the risk of having any form of diabetic retinopathy...
Clinical predictors of proliferative sickle cell retinopathy
Sickle Cell Disease (SCD) is an inherited disorder resulting in production of Haemoglobin S (HbS), which aggregates in conditions of hypoxia, acidosis or hyperosmolarity. This leads to vascular stasis, thrombosis and ischaemia. The authors present a cross-sectional study (45 consecutive...What's trending Jun/Jul 2023
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #whoopigoldberg #presbyopia #bionic Whoopi Goldberg made a name for herself in blockbusters such as the Oscar-winning Ghost and Sister Act. She...What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...ARVO (The Association for Research in Vision and Ophthalmology) 2025
i3: imagining innovation and intelligence in vision science This is an incredibly exciting time in ophthalmology and vision science research. Technological innovations have allowed us to probe the workings of the eye from the microscopic to the macroscopic level with...Money is a problem, but the problem is bigger than money
The argument surrounding doctors’ pay remains an ongoing battle. At the time of writing, Foundation Year 1 doctors have voted in favour of industrial action due to the lack of substantive employment or regular locum work at the end of...Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...The College of Optometrists celebrates 100 years of the international research journal Ophthalmic and Physiological Optics (OPO)
The College partners with Springer Nature to take OPO into its second century. The year 2025 marks the centenary of The College of Optometrists’ leading international and interdisciplinary research journal for contemporary vision science and optometry, Ophthalmic and Physiological Optics...All eyes on the future symposium hailed a great success
Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...
